FdaApplication

NDA 022287

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTAKEDA PHARMACEUTICALS USA INC
application_typeNDA
approval_date2009-01-30

Products (2)

ProductActive ingredientStrengthDosage form
DEXILANTDEXLANSOPRAZOLE60MGCAPSULE, DELAYED RELEASE;ORAL
DEXILANTDEXLANSOPRAZOLE30MGCAPSULE, DELAYED RELEASE;ORAL

2 products